816 related articles for article (PubMed ID: 25666611)
1. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Elmes MW; Kaczocha M; Berger WT; Leung K; Ralph BP; Wang L; Sweeney JM; Miyauchi JT; Tsirka SE; Ojima I; Deutsch DG
J Biol Chem; 2015 Apr; 290(14):8711-21. PubMed ID: 25666611
[TBL] [Abstract][Full Text] [Related]
2. A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs).
Deutsch DG
Front Pharmacol; 2016; 7():370. PubMed ID: 27790143
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
[TBL] [Abstract][Full Text] [Related]
4. Perinatal CBD or THC Exposure Results in Lasting Resistance to Fluoxetine in the Forced Swim Test: Reversal by Fatty Acid Amide Hydrolase Inhibition.
Maciel IS; Abreu GHD; Johnson CT; Bonday R; Bradshaw HB; Mackie K; Lu HC
Cannabis Cannabinoid Res; 2022 Jun; 7(3):318-327. PubMed ID: 34182795
[No Abstract] [Full Text] [Related]
5. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
6. Botanically-Derived Δ
Fitzpatrick JM; Hackett B; Costelloe L; Hind W; Downer EJ
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335126
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia.
Kaczocha M; Rebecchi MJ; Ralph BP; Teng YH; Berger WT; Galbavy W; Elmes MW; Glaser ST; Wang L; Rizzo RC; Deutsch DG; Ojima I
PLoS One; 2014; 9(4):e94200. PubMed ID: 24705380
[TBL] [Abstract][Full Text] [Related]
8. Identification of intracellular carriers for the endocannabinoid anandamide.
Kaczocha M; Glaser ST; Deutsch DG
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6375-80. PubMed ID: 19307565
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
10. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
Aly E; Masocha W
IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
[TBL] [Abstract][Full Text] [Related]
11. Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Eur J Neurosci; 2007 Apr; 25(7):2093-102. PubMed ID: 17419758
[TBL] [Abstract][Full Text] [Related]
12. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.
Massi P; Valenti M; Vaccani A; Gasperi V; Perletti G; Marras E; Fezza F; Maccarrone M; Parolaro D
J Neurochem; 2008 Feb; 104(4):1091-100. PubMed ID: 18028339
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
14. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
Hruba L; Seillier A; Zaki A; Cravatt BF; Lichtman AH; Giuffrida A; McMahon LR
J Pharmacol Exp Ther; 2015 May; 353(2):261-8. PubMed ID: 25711338
[TBL] [Abstract][Full Text] [Related]
16. The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.
Walentiny DM; Gamage TF; Warner JA; Nguyen TK; Grainger DB; Wiley JL; Vann RE
Eur J Pharmacol; 2011 Apr; 656(1-3):63-7. PubMed ID: 21300050
[TBL] [Abstract][Full Text] [Related]
17. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
[No Abstract] [Full Text] [Related]
18. A validated method for the simultaneous quantification of cannabidiol, Δ
Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS
Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
20. Δ
McIntosh AL; Martin GG; Huang H; Landrock D; Kier AB; Schroeder F
J Lipid Res; 2018 Apr; 59(4):646-657. PubMed ID: 29414765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
